Reported 2 days ago
Avidity Biosciences, Inc. (NASDAQ:RNA) is highlighted as one of the 'unstoppable stocks' that may double investors' money, with a 32% return over the past year and a potential upside of 107%. The company is developing innovative RNA-based medicines for rare genetic conditions and is set to submit a Biologics License Application by the end of 2025. Despite market volatility, analysts express optimism for stocks like Avidity, while also suggesting that investors should explore various sectors for growth opportunities.
Source: YAHOO